(Q42383384)

28 October 2017

Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary study (English)

1 reference

28 October 2017

1 reference

1

1 reference

28 October 2017

Holbrook IB

2

1 reference

28 October 2017

McClure J

series ordinal

3

1 reference

28 October 2017

George NJ

series ordinal

4

1 reference

28 October 2017

language of work or name

English

0 references

publication date

1 March 1991

1 reference

28 October 2017

4

1 reference

British Journal of Cancer

inferred from page(s)

published in

1 reference

28 October 2017

63

1 reference

28 October 2017

3

1 reference

28 October 2017

420-423

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1991.97

28 October 2017

0 references

cites work

Metastases in carcinoma; analysis of 1000 autopsied cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971879

Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971879

Biochemical and histological evidence that carcinoma of the prostate is associated with increased bone resorption

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971879

Management of pain and other symptoms of advanced prostatic cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971879

Bisphosphonates and bone metastases

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971879

Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971879

Mechanisms of bone destruction in the development of skeletal metastases

28 May 2018

1 reference

12 December 2020

Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia

1 reference

12 December 2020

Apposition and resorption of bone during oral treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)

1 reference

12 December 2020

Hormonal aspects of prostatic cancer: a review

1 reference

12 December 2020

Generalised increase in bone resorption in carcinoma of the prostate

1 reference

12 December 2020

Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment

1 reference

12 December 2020

Pamidronate to reduce bone pain in normocalcaemic patient with disseminated prostatic carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1991.97

1 reference

28 October 2017

1 reference

28 October 2017

PubMed publication ID

2003984

1 reference